Oasis Clinical Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Coeliac disease1 trial
• Migraine1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 11 trial
• Phase 21 trial
• Phase 31 trial

Status

• Recruiting3 trials

Lead sponsor

• Chugai Pharmaceutical1 trial
• Eli Lilly and Company1 trial
• TriGemX Bio, Inc.1 trial

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07816367· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Stephen Tam

• Recruiting

  Study of DONQ52 in Active Celiac Disease

  NCT07239336· Phase 2· Chugai Pharmaceutical· Source

• Recruiting

  A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

  NCT07258849· Phase 1· Eli Lilly and Company· Source

  Contact: Stephen Tam (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coeliac disease1 recruiting
• Migraine1 recruiting
• Rheumatoid arthritis1 recruiting